NCPA gearing up for busy two days on Capitol Hill tackling issues critical to community pharmacy
WASHINGTON — The National Community Pharmacists Association is expecting its highest turnout in two years for the association’s 2013 Legislative and Government Affairs conference being held Tuesday and Wednesday. NCPA intends to address many key issues impacting community pharmacy with legislators during the two-day conference.
The issues are paramount to keeping independent pharmacy owners in business. "[I am] concerned about the pushing out of smaller [healthcare] providers," Rep. Austin Scott, R-Ga., told journalists during a conference call Tuesday morning. "Without positive cash flow, the doors don’t stay open," he said, emphasizing the need to stop what most in the independent pharmacy community see as abusive audit practices by pharmacy benefit managers.
Establishing greater transparency in the operations of PBM was a recurring theme across NCPA’s legislative agenda over the next two days. "Small providers are being held hostage by a system that most people don’t understand," Scott added.
One of the many key issues for NCPA includes legislation that enables smaller pharmacies to compete across PBM pharmacy networks by instituting PBM audit reforms that prohibit abusive audits without eliminating altogether a tool to identify waste and fraud. Today, PBMs are so large and community pharmacy so small that the balance of power skews heavily in favor of PBMs, noted Doug Hoey, NCPA CEO. That’s not representative of a traditional business relationship, Hoey said. "We’re looking for balance."
As many as 24 states have instituted some form of audit reform legislation, Hoey noted. "Now it’s time for a uniform federal law."
Another critical issue for NCPA is MAC pricing for generics. MAC pricing is not updated frequently enough to accommodate generic cost spikes, Hoey said. "There’s no reason why, in this day and age, [MAC] prices cannot be updated instantaneously," Hoey suggested.
Other important issues NCPA members will address with leaders in Congress include creating an opportunity for community pharmacists to participate in PBM preferred networks, expand the role of the pharmacist to incorporate more medication therapy management reimbursement opportunities and compounding legislation.
Sato Pharmaceutical touts ZenTrip motion sickness solution to New Yorkers on the go
CARSON, Calif. — Sato Pharmaceutical, maker of ZenTrip, an over-the-counter motion sickness remedy, recently completed an outdoor urban panel promotion with Duane Reade drug stores in New York, driving trial to the remedy’s thin-film medicated strip.
Street-level displays were strategically placed throughout New York at subway entrances to reach multiple audiences with increased frequency, noted Russ Allison, Sato general manager U.S.
“As the first element in a well-rounded promotion program, urban panels act as people magnets, helping us achieve our goal in building brand awareness of ZenTrip and its manifold advantages over older brands on retail shelves,” he said.
NCPA highlights Taxpayers Protection Alliance report criticizing mail-order pharmacy
ALEXANDRIA, Va. — Federal prescription drug programs are more susceptible to waste, fraud and abuse because of the lack of transparency and oversight of mail-order pharmacy, proclaimed the Taxpayers Protection Alliance on Tuesday in a report called “The Expensive Truth Behind Taxpayer-Funded Mail Order Pharmaceuticals.”
The National Community Pharmacists Association has committed to drawing further attention to the report as it advocates for patient choice of pharmacy and PBM reform with policymakers and health plan sponsors today.
“The mission of the Taxpayers Protection Alliance is to hold the government accountable when taxpayers who fund government programs are being ill-served, so mail-order waste is a fitting area of focus," stated Doug Hoey, NCPA CEO. "As the TPA report notes, unused or unneeded medication shipped from mail order warehouses is a prime source of taxpayer-funded waste that policymakers should address.”
“Given the significant and disconcerting shortcomings of the mail-order delivery programs, policy changes must be implemented to address the issues discussed in this report," TPA stated. "For starters, PBMs must adhere to and provide common sense forms of disclosure. Protecting patients and their ability to access the pharmacy of their choice is of great importance. Taxpayers … deserve transparency.”